3 Reasons Why Investing in Coronavirus Vaccine Stocks Is a Sucker’s Game
Biotech firms developing coronavirus vaccines have surged in recent weeks as cases and deaths rise. The history of vaccine development is riddled with failure. None of the recent human coronavirus strains have a vaccine yet despite SARS appearing nearly two decades ago. Global coronavirus cases are now over three million, while deaths have surpassed the…